26197 Efficacy and safety of risankizumab vs methotrexate in patients with moderate-to-severe plaque psoriasis: Results from the 28-week randomized, double-blind period of an ongoing phase 3 study in Brazil.

Details

Language :

English

ISSN :

01909622

Volume :

85

Issue :

3

Database :

Supplemental Index

Journal :

Journal of the American Academy of Dermatology

Publication Type :

Academic Journal

Accession number :

151801952

Full Text :

https://doi.org/10.1016/j.jaad.2021.06.375